Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma This phase II trial studies how well dovitinib works in treating patients with recurrent or progressive glioblastoma. Dovitinib may stop the growth of tumor cells by blocking some of the e...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma This phase II trial will investigate the efficacy and safety of the addition of Optune (Tumor Treating Fields or TTF Therapy) to bevacizumab for patients with bevacizumab-refractory recurr...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Primary Central Nervous System Non-Hodgkin Lymphoma This phase II trial studies how well yttrium Y 90 ibritumomab tiuxetan and rituximab work in treating patients with recurrent or refractory primary central nervous system non-Hodgkin lymph...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma This phase II trial studies how well methoxyamine works when added to standard temozolomide in treating patients with glioblastoma that has come back. Drugs used in chemotherapy, such as m...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Terameprocol in Treating Patients With Recurrent High Grade Glioma This phase I trial studies the side effects and best dose of terameprocol in treating patients with high-grade glioma that has come back. Drugs used in chemotherapy, such as terameprocol, ...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Feasibility Study on LITT for Newly Diagnosed Glioblastoma Multicenter, open-label, prospective designed study to characterize the performance of brain laser interstitial thermal therapy (LITT) ablation using the Monteris NeuroBlate System in comb...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune